Triiodothyronine exerts a major pleiotropic effect on reverse cholesterol transport phenotypes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 2, 1996, Pages 289-293

  Comuzzie, Anthony G ^a   Blangero, J ^a   Mahaney, Michael C ^a   Sharp, R Mark ^a   Vandeberg, John L ^a   Stern, Michael P ^b   MacCluer, Jean W ^a  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

apo AI; apo AII; HDL C; LpAI; thyroid hormones

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LIPOPROTEIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; UNITED STATES;

EID: 0030022059     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.2.289     Document Type: Article

References (17)

1. Samuels HH, Forman BM, Horowitz ZD, Zheng-Sheng Y. Regulation of gene expression by thyroid hormone. J Clin Invest. 1988;81:957-967.
2. Muls E, Rosseneu M, Blanton V, Lesaffre E, Lamberigts G, DeMoor P. Serum lipids and apolipoproteins A-I, A-II, and B in primary hypothyroidism before and during treatment. Eur J Clin Invest. 1984;14:12-23.
3. Muls E, Blaton V, Rosseneu M, Lesaffre E, Lamberigts G, DeMoor P. Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment. J Clin Endocrinol Metab. 1982;55:459-467.
4. Muls E, Rosseneu M, Bury J, Stul M, Lamberigts G, DeMoor P. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man. J Clin Endocrinol Metab. 1985;61:882-889.
5. Romney JS, Chan J, Carr FE, Mooradian AD, Wong NCW. Identification of the thyroid hormone-responsive messenger RNA spot 11 as apolipoprotein-A1 messenger RNA and effects of the hormone on the promoter. Mol Endocrinol. 1992;6:943-950.
6. Hogle DM, Smith RS, Curtiss LK. Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay. J Lipid Res. 1988;29:1221-1229.
7. Stein EA, DiPersio L, Pesce AJ, Kashyap M, Kao JT, Srivastava L, McNerney C. Enzyme-linked immunoabsorbant assay of apolipoprotein All in plasma, with use of a monoclonal antibody. Clin Chem. 1986;32:967-971.
8. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
9. Boehnke M, Moll PP, Kottke BA, Weidman WH. Partitioning the variability of fasting plasma glucose levels in pedigrees. Am J Epidemiol. 1987;125:679-689.
10. Hopper JL, Mathews JD. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet. 1982;46:373-383.
11. Lange K, Boehnke M. Extensions to pedigree analysis, IV: covariance components models for multivariate traits. Am J Med Genet. 1983;14:513-524.
12. Blangero J, Konigsberg LW. Multivariate segregation analysis using the mixed model. Genet Epidemiol. 1991;8:299-316.
13. Hasstedt SJ. Pedigree Analysis Package. Revision 3.0. Salt Lake City, Utah: Department of Genetics, University of Utah; 1989.
14. Williams-Blangero S, Blangero J. Quantitative genetic analysis of skin reflectance: a multivariate approach. Hum Biol. 1992;64:35-49.
15. Comuzzie AG, Blangero J, Mahaney MC, Mitchell BD, Stern MP, MacCluer JW. Genetic and environmental correlations among skinfold measures. Int J Obes Relat Metab Disord. 1994;18:413-418.
16. Graybill FA. Theory and Application of the Linear Model. Belmont, Mass: Duxbury Press; 1976.
17. Beaty TH, Self SG, Liang KY, Connolly MA, Chase GA, Kwiterovich PO. Use of robust variance components models to analyse triglyceride data in families. Ann Hum Genet. 1985;49(pt 4):315-328.